Our preliminary data indicates that both HAX1 and uPAR are simultaneously increased in aggressive (e.g., MDA-MB-231 and PC3) but not in nonaggressive (e.g., MCF-7) cancer cells. This evidence concerns the gene HAX1 and cancer.